No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 9, 2009, Pages 2553-2557

  Teras, Lauren R ^a,b   Goodman, Michael ^b   Patel, Alpa V ^a   Bouzyk, Mark ^b   Tang, Weining ^b   Diver, W Ryan ^a   Feigelson, Heather Spencer ^c  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; LEPTIN; LEPTIN RECEPTOR;

AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NON PROFIT ORGANIZATION; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADIPONECTIN; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LEPTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RECEPTORS, ADIPONECTIN; RECEPTORS, LEPTIN; RISK FACTORS;

EID: 70349317352     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0542     Document Type: Article

References (30)

1. Housa D, Housova J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiol Res 2006;55:233-244
2. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006;13:279-292 (Pubitemid 43886659)
3. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153-165 (Pubitemid 38998240)
4. Hu X, Juneja SC, Maihle NJ, Cleary MP. Leptin - a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002;94:1704-1711 (Pubitemid 35446839)
5. Okumura M, Yamamoto M, Sakuma H, et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression. Biochim Biophys Acta 2002;1592:107-116
6. Catalano S, Marsico S, Giordano C, et al. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 2003;278:28668-28676 (Pubitemid 36935773)
7. Somasundar P, Yu AK, Vona-Davis L, McFadden DW. Differential effects of leptin on cancer in vitro. J Surg Res 2003;113:50-55 (Pubitemid 36999792)
8. Catalano S, Mauro L, Marsico S, et al. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor α in MCF-7 cells. J Biol Chem 2004;279:19908-19915 (Pubitemid 38623433)
9. Yin N, Wang D, Zhang H, et al. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 2004;64:5870-5875 (Pubitemid 39095588)
10. Garofalo C, Koda M, Cascio S, et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006;12:1447-1453
11. Garofalo C, Sisci D, Surmacz E. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 2004;10:6466-6475 (Pubitemid 39346542)
12. Kang JH, Lee YY, Yu BY, et al. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 2005;28:1263-1269 (Pubitemid 41772422)
13. Dieudonne MN, Bussiere M, Dos Santos E, et al. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2006;345:271-279
14. Korner A, Pazaitou-Panayiotou K, Kelesidis T, et al. Total and high molecular weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 2006;0:0.
15. Wang Y, Lam JB, Lam KS, et al. Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 2006;66:11462-11470 (Pubitemid 46009979)
16. Arditi JD, Venihaki M, Karalis KP, Chrousos GP. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 2007;39:9-13. (Pubitemid 46535150)
17. Miyoshi Y, Funahashi T, Kihara S, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;9:5699-5704 (Pubitemid 37499493)
18. Mantzoros C, Petridou E, Dessypris N, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004;89:1102-1107
19. Chen DC, Chung YF, Yeh YT, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 2006;237:109-114
20. Kang JH, Yu BY, Youn DS. Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 2007;22:117-121
21. Tworoger SS, Eliassen AH, Kelesidis T, et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 2007;0:0. (Pubitemid 46556432)
22. Gallicchio L, McSorley MA, Newschaffer CJ, et al. Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detect Prev 2007;31:95-101. (Pubitemid 46669815)
23. Han CZ, Du LL, Jing JX, et al. Associations among lipids, leptin, and leptin receptor gene Gin223Arg polymorphisms and breast cancer in China. Biol Trace Elem Res 2008;126:38-48.
24. Liu CL, Chang YC, Cheng SP, et al. The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 2007;72:75-81.
25. Woo HY, Park H, Ki CS, Park YL, Bae WG. Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett 2006;237:137-142
26. Snoussi K, Strosberg AD, Bouaouina N, et al. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 2006;6:38. (Pubitemid 43380715)
27. Feigelson HS, Teras LR, Diver WR, et al. Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res 2008;10:R57.
28. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-120
29. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-874 (Pubitemid 47014500)
30. Kaklamani VG, Sadim M, Hsi A, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res 2008;68:3178-3184